Researchers Identify Key Role of HERC2 Gene in Rare Neurodevelopmental Syndrome

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona have made a significant breakthrough in understanding a rare neurodevelopmental syndrome caused by mutations in the HERC2 gene. This condition shares clinical features with Angelman syndrome and causes global developmental delay in affected individuals. The discovery advances understanding of the genetic mechanisms underlying this minority neurodevelopmental disorder. This research may lead to better diagnostic approaches and potential therapeutic strategies for patients with HERC2-related developmental conditions.